Justin Xiang, PhD
Dr. Xiang is the Chief Investment Officer and Co-Founder of Syno Capital, a global healthcare and biotech investment firm based in New York City that emphasizes on cross-border collaborations between United States and China. In addition, Dr. Xiang is a senior advisor to Zhong An Insurance, a pioneer online insurance platform in China jointly led by Alibaba, Tencent and Ping An Insurance. He advises the firm on healthcare-related products and manages executive-level investor relations. Dr. Xiang also serves as Board Director Orig3n, a stem cell (iPSC) technology company in Boston, MA.